Introduction {#sec1-1}
============

Epilepsy is a brain disorder which is characterized by seizures that induced by a complex of neurotransmitter systems. This disorder is one of the most common neurological impair which affect about 50 million people in the entire world.\[[@ref1]\] Approximately 5-10% of the world population experience epilepsy in their lifetime that occurring during early childhood or late adulthood.\[[@ref2]\] This disorder, if untreated, can lead to impaired intellectual function or death and is typically accompanied by psychopathological consequences. Currently, many synthetic drugs like carbamazepine, ethosuximide, gabapentin, oxcarbazepine, phenobarbital, phenytoin, valproic acid, felbamate, etc. are used as potent anti-epileptic agents, but they are not free from marked side effects.\[[@ref3]\] There is some difficulty in the treatment procedure of epilepsy, for example, approximately 30% of the patients continue to have seizures with current anti-epileptic drug therapy and these drugs have the serious side effects and chronic toxicity.\[[@ref4]\] Hence, there is a need to address a potent alternative as anti-epileptic agent with minimal side effects. In the recent years, there is an increasing interest to use natural sources which would be a valuable agent for finding the new therapeutic drugs. In Iranian traditional medicine, there are some medicinal plants which were used for the treatment of epilepsy.\[[@ref5]\] Plants of the genus *Ferula* belongs to the family of *Apiaceae* include about 130 species that distributed throughout central Asia and Mediterranean area.\[[@ref6]\] *Ferula assa-foetida L*. is one of these species that grows wildly in central area of Iran. The part used of this plant and several other species of *Ferula* is an oleo gum resin (asafoetida) that obtained by incision of stem and root. This oleo gum resin is considered as an important matter of pharmacological and industrial application. The gum fraction of asafoetida contains the glucuronic acid, galactose, arabinose, and rhamnose and its resin is consisting of umbelliferone, ferulic acid and its esters, coumarins, sesquiterpene coumarins, and other terpenoids.\[[@ref7]\] In Iranian folk medicine, asafoetida have been used for anti-convulsant, anti-spasmodic, carminative, digestive, expectorant, sedative, anti-hysteric, laxative, aphrodisiac, anti-septic, and analgesic activities.\[[@ref5]\] Recent pharmacological and biological studies have also shown several activities, such as anti-oxidant, anti-viral, anti-fungal, cancer chemopreventive, anti-diabetic, anti-spasmodic, hypotensive, and molluscicidal from this oleo gum resin.\[[@ref7]\] In some previous studies; possible anti-convulsant effect of some *Ferula* species has been investigated. Studies on *F gummosa* acetone root extract showed that this extract has anti-convulsant activity in generalized epilepsy in mice.\[[@ref8]\] Our previous study showed that methanolic extract of some different *Ferula* species did not any effect on generalized epileptic behavior in mice.\[[@ref6]\] In this study, to confirm the evidence of this folk medicine for the anti-convulsant activity, we experiment anti-convulsant effect of asafoetida in chemical and amygdala-kindled rats.

Materials and Methods {#sec1-2}
=====================

Animals {#sec2-1}
-------

Male Wistar rats (aged 8 weeks at the beginning of the experiments), 180-250 g, were reared in the animal house and kept under controlled standard condition of 20 ± 2ºC and 12-L/12-D photoperiod. Rats were housed and maintained on a standard tap water and commercial rat pellet diet. The experimental protocol was approved by the Ethic Committee of Shahid Sadoghi University of Medical Sciences.

Plants material and chemical {#sec2-2}
----------------------------

*Ferula assa-foetida* oleo gum resin (asafoetida) was collected from Tabas region (Yazd province, Iran) during the summer and the plant species was botanically identified by Dr. Abbas Zarezadeh in Yazd Agricultural Research Center. The dried powder of asafoetida was soaked in distilled water overnight at room temperature and the yielded suspension was used orally. Concentrations and dosages of the extract were expressed as crude amount of the dried oleo gum resin used in preparing the stock solution. Pentilen tetrazol (PTZ) (Sigma, USA) were dissolved in saline and prepared to use intraperitoneally.

Experiment 1 {#sec2-3}
------------

### PTZ kindling procedure {#sec3-1}

Twenty-four male Wistar rats were divided equally and randomly to four groups (one control and three test groups). Treatment animals received orally asafoetida in dose of 50 and 100 mg/kg 90 minute prior to PTZ injection in a subconvulsive dose of 35 mg/kg i.p. Control group received saline 90 minute before injection of PTZ (35 mg/kg i.p). After each injection of PTZ, the animals were placed individually in plastic boxes. Convulsive behavior was recorded for 30 minutes and behavioral changes were scored according to Racine\'s criteria as follows: Stage 0: No response, stage 1: Ear and facial twitching, stage 2: Myoclonic jerks without rearing, stage 3: Myoclonic jerks with rearing, stage 4: Turn over into side position, clonic--tonic seizures, stage 5: Turn over into back position, generalized clonic--tonic seizures.\[[@ref9]\]

Experiment 2: Electrical kindling {#sec2-4}
---------------------------------

### Surgical procedure {#sec3-2}

Eighteen rats were anesthetized i.p. with ketamine hydrochloride (100 mg/kg) and xylazine (10 mg/kg) and placed in a Stoelting stereotaxic instrument. Bipolar stimulating and monopolar recording electrodes were stereotaxically implanted in the basolateral amygdala of the right the hemisphere (coordinates: anteroposterior (AP), −2.5 mm; mediolateral (ML), 4.8 mm; dorsoventral (DV), 7.5 mm) according to Paxinos and Waston.\[[@ref10]\] The electrodes (Teflon-coated, 125 μm in diameter; A.M. system Inc., USA) were insulated except at their tips. Two other electrodes were connected to the skull screws and placed above the left cortical surface as earth and differential electrodes. The pines attached to the electrodes were inserted into a socket which was fixed on the skull. A 23-gauge guide cannula was also implanted in the right lateral ventricle (coordinates: AP, −1.0 mm; ML, 1.2 mm; DV, 3.6 mm).

### Kindling procedure {#sec3-3}

One week after the surgery, after discharge (AD) threshold was determined in the amygdala by 2 second, 60 Hz monophasic square wave stimulus of 1 ms per wave. Stimulation was provided by a stimulator and constant current stimulus isolation unit (WSI, Iran). The Stimulation were initially delivered at 10 μA and then at 5-minutes intervals increasing stimulus intensity in increments of 10 μA until at least 5 second of after discharges were recorded as previously described.\[[@ref11]\] Then, animals were stimulated daily at AD threshold intensity until three consecutive stage 5 seizures (fully kindled) according to Racine scales were elicited.\[[@ref9]\] Subsequent to amygdala stimulation, convulsive behaviors and electrophysio-logical parameters including after discharge duration (ADD), stage 4 latency (S4L), stage 5duration (S5D) were recorded.

### Experimental groups and treatments {#sec3-4}

The effect of *Ferula assa-foetida* oleo gum resin on the kindled rats and kindling development was determined. Rats were first fully kindled with daily amygdala stimulations and then, seizure parameters of fully kindled rats in the last stimulation session were recorded as control data. One day later, rats received asafoetida orally in dose of 50, 100 mg/kg 90 min prior to electrical stimulation. After each electrical stimulation, S4L, S5D, SD, and ADD were recorded. Effects of asafoetida on the kindling development were evaluated in separate groups; rats received asafoetida at the doses of 50, 100 mg/kg 90 minute prior to each electrical stimulation. After amygdala stimulation, epileptic behaviors, and electrophysiological parameters were monitored and scored for 30 minutes.

Statistical analysis {#sec2-5}
--------------------

Scores of seizure stages were compared using Kruskal--Wallis one-way analysis of variance (ANOVA) on ranks followed by multiple comparison tests. Results of S4L and S5D were compared using one-way and repeated measure ANOVA. Tukey\'s test was employed to compare the differences among treated groups using Graph pad prism version 5. The *P*-value less than 0.05 were considered to be statistically significant.

Results {#sec1-3}
=======

Effects of asafoetida on PTZ kindling development {#sec2-6}
-------------------------------------------------

Pretreatment animals with asafoetida at 50 and 100 mg/kg significantly reduced the mean seizure stage during the 20 kindling injection as compared with the saline control animals \[*P* \< 0.05, [Figure 1](#F1){ref-type="fig"}\].

![Effect of asafoetida pretreatment on the PTZ-induced kindling intensity. \**P* \< 0.05 indicates significant differences as compared to PTZ-kindled group](NAJMS-6-408-g001){#F1}

Effects of asafoetida in amygdala-kindled rats {#sec2-7}
----------------------------------------------

In amygdale-kindled rats, asafoetida at the doses of 50 and 100 mg/kg led to decrease in SD, S5D, and ADD \[*P* \< 0.05, [Figure 2](#F2){ref-type="fig"}\]. S4L was significantly longer in the asafoetida treated-than saline treated rats (*P* \< 0.05). In the groups that treated with asafoetida before each amygdala stimulation, cumulative S4L was significantly longer than control group. Cumulative S5D, cumulative SD, and cumulative ADD were significantly decreased in asafetida-treated rats \[*P* \< 0.05, [Figure 3](#F3){ref-type="fig"}\]. [Figure 4](#F4){ref-type="fig"} showed the effect of asafoetida administration on the number of stimulations needed to achieve different seizure stages. There is a significant increase in the number of stimulations to seizure stage 3, 4, and 5 in asafetida-treated rats at both doses (*P* \< 0.05).

![Effect of asafoetida at the doses of 50 and 100 mg/kg on SD, S4L, S5D, and ADD. \**P* \< 0.05 indicates significant differences as compared to control. *ADD* after discharge duration, *S5D* stage 5 duration, *SD* seizure duration, *S4L* stage 4 latency](NAJMS-6-408-g002){#F2}

![Effect of asafoetida at the doses of 50 and 100 mg/kg on cSD, cS4L, cS5D, and cADD. \**P* \< 0.05 indicates significant differences as compared to control. cSD cumulative seizure duration. cS4L cumulative stage 4 latency. cS5D cumulative stage 5 duration. cADD cumulative after discharge duration](NAJMS-6-408-g003){#F3}

![Effect of asafoetida administration on the number of stimulations. \**P* \< 0.05 indicates significant differences as compared to control group](NAJMS-6-408-g004){#F4}

Discussion {#sec1-4}
==========

In this study, our results showed that asafoetida had an obvious anti-convulsant effect in PTZ and amygdala-kindled rats. In Ayurveda, asafoetida is introduced as a valuable remedy for hysteria and nervous disorders and American people also orally use it as a stimulant to the brain and nerves.\[[@ref7]\] In Iranian traditional medicine, the gum obtained from *F. gumosa*, *F. assa-foetida*, *F. badrakema*, and *F. diversivittata* have been used as an anti-epileptic remedy.\[[@ref5]\] There are several studies that investigated anti-convulsant activity of some *Ferula* species. Sayyah *et al*., reported that seed and root acetone extracts of *Ferula gummosa* have anti-convulsant activity in mice.\[[@ref8][@ref12]\] They proposed that the anti-seizure profile of *F. gummosa* seed acetone extract may be related in part to monoterpenes and terpenoid compound present in the extract. They also mentioned that fruit essential oil of *F. gummosa* has anti-epileptic potential.\[[@ref13]\] In previous study, we reported that some methanolic extract of *Ferula* species could not prevent PTZ-induced seizure.\[[@ref6]\] The controversy results about the anti-epileptic effect of these extracts may be related to epileptic model and/or extracting method. Kiasalari *et al*., showed that hydro-alcoholic extract of asafoetida is able to reduce seizure duration and its intensity and this anti-seizure effects is dependent to dosage.\[[@ref14]\] They concluded that anti-oxidant activity of this extract maybe has a role to preventive of seizure. They also showed that malondialdehyde (MDA) and nitric oxide (NO) levels decreased in the brain tissue. The results of this research are consistent with the results obtained in our study. Our data showed that asafoetida with dose 100mg/kg has generally had a better effect in reducing the severity convulsive and other parameters of seizures. In this group, number of stimulations that needed to achieve different seizure stages increased significantly \[[Figure 4](#F4){ref-type="fig"}\]. Cumulative S4L, cS5D, cSD, and cADD were significantly longer than control group and these parameters were more effective at asafoetida100mg/kg. PTZ kindling model is a common model and is valid model for human generalized myoclonic seizures and also generalized seizures of the absence type.\[[@ref15]\] As shown in [Figure 1](#F1){ref-type="fig"}, our results also indicated that asafoetida could decrease the intensity of seizure in PTZ kindle model. This type of seizures can be prevented by drugs that enhance gamma amino butyric acid type A (GABAA) receptor mediated inhibitory neurotransmission, such as benzodiazepines and Phenobarbital and perhaps valproate and felbamate.\[[@ref8]\] Drugs that reduce T-type calcium current, such as ethosuximide can also prevent seizures induced by PTZ. Although the anti-convulsant mechanism of *Ferula* genus has not been identified, there are some hypotheses about these effects. Sayyah *et al*., suggested that maybe existence of monoterpenes including α-Pinene and β-Pinene (with anti-epileptic properties) ceased anti-convoulsant property.\[[@ref13]\] Linalool is another monoterpene compound, which has protective effect against PTZ-, picrotoxin-, and *N*-methyl-[D]{.smallcaps}-aspartate (NMDA)-induced convulsions.\[[@ref16]\] Moreover, pinene, eugenol and methyleugenol exhibited anti-convulsant profile in some experimental seizures such as maximum electroshock (MES) and PTZ tests.\[[@ref17][@ref18]\] Modulation of glutamatergic and GABAergic transmission is some mechanisms indicated for anti-convulsant action of the monoterpenes like linalool and eugenol.\[[@ref16][@ref19][@ref20]\] Therefore, it seems that the anti-seizure profile of asafoetida may be related in part to monoterpens and terpenoid compounds present in the root because these compounds were also detected in *Ferula assa- foetida*.\[[@ref21][@ref22]\] It was determined that pinene analogs prevent idiopathic epilepsy in prone mice.\[[@ref23]\] In addition, flavonoid compounds with anti-oxidant properties are among the fractions of *Ferula* plants and could be another candidate by which the anti-convulsant effect of *Ferula* is occurred. Phytochemistry of asafoetida demonstrated that this oleo gum resin is the rich presence of alkaloids, flavonoids and acidic compounds. A large number of different sesquiterpene coumarins have been reported from asafoetida. The compounds of *Ferula assa-foetida* are not limited to sesquiterpene coumarins; it also contains some other compounds belonging to different classes of natural products, such as diterpenes phenolics, acetylenes, sesquiterpenes, and sulfur compounds.\[[@ref24]\]

Conclusion {#sec1-5}
==========

According to the present study, we concluded that asafoetida has an anti-convulsant effect that this observation confirms the use of this plant in traditional medicine. However, further investigations including chronic toxicity studies and activity-guided fractionation must be performed in order to assess the real toxicological profile and the active compounds and mechanism action of this oleo gum resin.
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